But few randomized clinical trials have been conducted of GLP-1s for treatment of AUD
If youre in overall good health without any untreated underlying conditions, and meet the appropriate weight loss criteria, then most likely the answer is yes
Lower Rate Signal In one study, researchers at the University of Pennsylvania examined electronic health records from women who had undergone breast imaging between January 2022 and June 2025
Finally, heres the crucial fact which the media fails to mention: the study was conducted on people taking GLP-1 meds for diabetes management not people taking GLP-1 meds for weight loss
Most major health insurance coverage plans, including commercial plans like Medicare, and many Medicaid plans, cover Ozempic for eligible patients with a diagnosis of Type-2 diabetes
About 11% of people 65 years and older said they were utilizing the weight-loss medications